H

HeartBeat.bio AG

13 employees

HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
iPS Cells
Heart Failure
Cardiac Organoids
High-Throughput Drug Discovery Platform
Heart Regeneration
Cardio-Oncology
Human 3D Disease Modelling
Cardiotoxicity
Cardiomyopathy
Cardiac Drug Discovery
Medical
Myocardial Infarction

Date founded

2021

Funding rounds raised

Total raised

$1.8M

from 1 investors over 1 rounds

H

HeartBeat.bio AG raised $1.8M on May 4, 2021

Investors: red-stars.com data AG

FAQ